AJJ Medtech Holdings Limited Announces Completion of S\$918,000 Share Placement

Key Highlights

• AJJ Medtech Holdings Limited has successfully completed the placement of 127,499,998 new ordinary shares at an issue price of S\$0.0072 per share, raising an aggregate consideration of S\$918,000.
• The new shares were allotted and issued to eight individual investors following the receipt of full placement consideration.
• This placement increases the Company’s total issued and paid-up ordinary shares from 1,584,038,302 to 1,711,538,300.
• The Placement Shares will be listed and quoted on the Catalist board of the Singapore Exchange (SGX-ST) from 9.00 a.m. on 25 November 2025.

Details of the Placement

The share placement was conducted according to the terms and conditions of the Placement Agreement. The Company allotted the shares as follows:

• Chua Soo Rui – 6,944,444 shares
• Yap Yong Song – 6,944,444 shares
• Guo Wenqun – 12,500,000 shares
• Ho Jack Hung – 13,888,888 shares
• Chua June Gay – 37,222,222 shares
• Nicholas Jeyaraj S/O Narayanan – 5,000,000 shares
• Bai Hongfu – 25,000,000 shares
• Ong Bee Huat – 20,000,000 shares

Shareholder Implications & Price Sensitivity

• Dilution Effect: The placement will result in a dilution of existing shareholders’ equity due to the increase in issued shares. The total share capital now stands at 1,711,538,300 shares, up from 1,584,038,302 shares. This is a significant increase and may affect per-share metrics such as earnings per share (EPS) and net asset value per share.
• Placement Price: The shares were placed at S\$0.0072, which could serve as a near-term reference price for the market. Existing shareholders should monitor how the market responds to the new supply of shares at this price level.
• Investor Mix: The shares have been distributed among several individual investors, which may influence future shareholding patterns and voting rights.
• Listing Date: The new shares will be tradable from 25 November 2025, potentially increasing liquidity in the counter.
• Dividend Rights: Placement Shares will rank pari passu with existing shares except that they will not be eligible for dividends, rights, allotments, or distributions where the record date falls on or before the completion date.

Potential Impact on Share Price

The successful completion of the placement and capital injection of S\$918,000 is a noteworthy development for AJJ Medtech Holdings Limited. The increase in share capital and the introduction of new investors may lead to changes in market sentiment and trading dynamics. The placement price may also serve as a benchmark for future price movements. Investors should closely monitor trading activity following the listing of the Placement Shares on 25 November 2025.

Corporate Governance & Regulatory Notes

• This placement has been reviewed by the Company’s sponsor, Evolve Capital Advisory Private Limited, but not by the Singapore Exchange Securities Trading Limited (SGX-ST), which assumes no responsibility for the contents of the announcement.
• Contact for sponsor-related matters: Mr. Jerry Chua, Tel: (65) 6241 6626, at 160 Robinson Road, #20-01/02, SBF Centre, Singapore 068914.

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any securities. Investors should conduct their own independent research and consult professional advisors before making investment decisions. The information herein is based on the Company’s official announcements and is subject to change or update without notice.

View AJJ Medtech Historical chart here